Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study the benefits of giving chemotherapy to women after they
have had surgical resection of their primary disease and have no evidence of disease
remaining(known as adjuvant therapy). The major objective of this study is to determine the
progression free survival. The goal is to prevent relapse or recurrence of their uterine
leiomyosarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
Sarcoma Alliance for Research through Collaboration